Pulse Biosciences Inc.

NASDAQ: PLSE · Real-Time Price · USD
16.12
-1.19 (-6.87%)
At close: Aug 15, 2025, 12:34 PM

Pulse Biosciences Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
1.66M 1.66M 1.66M 1.74M 1.74M 1.74M 1.74M -9K -9K 256K 700K 1.55M 2.13M 1.86M 1.42M 574K n/a n/a
Cost of Revenue
1.38M 1.65M 1.66M 1.14M 1.14M 1.17M 1.17M 2.16M 10.29M 11.34M 11.94M 11.89M 4.22M 3.14M 2.51M 1.27M 712K 613K
Gross Profit
282K 16K n/a 604K 605K 569K 566K -2.17M -10.3M -11.08M -11.24M -10.34M -2.09M -1.28M -1.1M -699K -712K -613K
Operating Income
-72.23M -63.69M -56.26M -48.53M -46.13M -44.63M -43.57M -39.79M -46.56M -50.35M -58.06M -64.72M -60.97M -61.76M -63.01M -61.36M -59.99M -56.54M
Interest Income
3.1M 3.44M 2.67M 2.4M 2.11M 2.08M 2.16M 1.83M 1.16M 860K 299K 32K 18K n/a n/a 6K 15K 36K
Pretax Income
-68.03M -60.24M -53.59M -46.13M -44.02M -42.55M -42.21M -39.47M -46.95M -51.03M -58.51M -64.72M -60.97M -62.29M -63.66M -61.99M -60.61M -56.62M
Net Income
-68.03M -60.24M -53.59M -46.13M -44.02M -42.55M -42.69M -39.92M -47.41M -51.48M -58.47M -64.72M -60.95M -62.29M -63.66M -61.99M -60.61M -56.62M
Selling & General & Admin
31.47M 27.51M 23.36M 18.19M 16.02M 15.31M 15.47M 14.39M 15.72M 19.67M 25.97M 31.98M 34.53M 34.4M 33.82M 30.8M 29.08M 27.21M
Research & Development
40.77M 35.91M 32.34M 29.47M 29.24M 28.71M 27.8M 24.09M 21.14M 19.9M 20.84M 22.4M 24.34M 26.35M 28.64M 30.41M 30.91M 29.33M
Other Expenses
n/a n/a n/a 304K 304K 304K 304K n/a n/a n/a n/a n/a n/a n/a n/a n/a 166K 333K
Operating Expenses
72.23M 63.42M 55.69M 47.96M 45.56M 44.33M 43.57M 38.49M 36.86M 39.57M 46.81M 54.38M 58.88M 60.75M 62.46M 61.21M 59.99M 56.54M
Interest Expense
n/a n/a n/a n/a n/a n/a 800K 1.25M 1.27M 1.27M 466K 20K 15K 532K 646K 640K 631K 114K
Selling & Marketing Expenses
n/a -266K -565K -869K -869K -603K -304K 768K 2.79M 6.48M 12.02M 15.3M 16.69M 16.15M 14.75M 13.03M 11.37M 9.71M
Cost & Expenses
72.23M 63.69M 56.26M 48.53M 46.13M 44.63M 43.57M 39.78M 46.55M 50.6M 58.76M 66.28M 63.1M 63.62M 64.43M 61.93M 59.99M 56.54M
Income Tax Expense
n/a n/a n/a n/a n/a n/a 478K 450K 464K 446K -32K -4K -18K n/a n/a n/a n/a n/a
Shares Outstanding (Basic)
67.28M 67.13M 58.4M 61.07M 57.18M 55.17M 55.06M 54.92M 44.51M 37.39M 37.23M 37.16M 31.49M 29.75M 29.64M 29.61M 26.48M 26.07M
Shares Outstanding (Diluted)
67.28M 67.13M 58.4M 61.07M 57.18M 55.17M 55.06M 54.92M 44.51M 37.39M 37.23M 37.16M 31.49M 29.75M 29.64M 29.61M 26.48M 26.07M
EPS (Basic)
-1.07 -0.99 -0.92 -0.81 -0.79 -0.81 -0.9 -0.93 -1.23 -1.45 -1.76 -2.03 -2.02 -2.16 -2.29 -2.31 -2.34 -2.29
EPS (Diluted)
-1.07 -0.99 -0.92 -0.81 -0.79 -0.81 -0.9 -0.93 -1.23 -1.45 -1.76 -2.03 -2.02 -2.16 -2.29 -2.31 -2.34 -2.29
EBITDA
-71.65M -62.81M -55.08M -47.33M -44.93M -43.42M -42.37M -38.55M -45.28M -49.02M -56.7M -63.41M -59.71M -60.57M -61.87M -60.23M -58.88M -55.44M
EBIT
-50.71M -62.44M -56.26M -48.53M -46.13M -44.63M -43.57M -39.79M -46.56M -50.35M -58.06M -64.72M -60.97M -61.76M -63.01M -61.36M -59.99M -56.54M
Depreciation & Amortization
864K 1.13M 1.15M 1.16M 1.14M 1.17M 1.17M 1.21M 1.28M 1.34M 1.37M 1.33M 1.26M 1.16M 1.11M 1.1M 1.09M 1.1M